Advertisement

NGM Biopharmaceuticals, Inc. NGM

Set alert

Price alert · NGM

All alert types
1.54 +1.54 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
128.53M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-2.05
Beta
1.26
Short ratio
1.26
Inst. own
54.16%
Dividend
0.00
Ex-div date
Earnings
May 2, 2024
50-d avg
1.55
200-d avg
1.47
1y target
1.66

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NGM has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $1.99MExpenses → Gross Loss: $353.00KExpenses → Selling, General & Admin: $7.94MExpenses → Research & Development: $21.37MNet Loss → Expenses: $27.67MRevenue → Cost of Revenue: $165.00KOther Income$1.99MNet Loss$27.67MCost of Revenue$518.00KExpenses$29.66MGross Loss$353.00KSelling, General & Admin$7.94MResearch & Development$21.37MRevenue$165.00K

Period ending Dec 31, 2023 · select a line to chart its history

Income statement

NGM quarterly income statement
29.83M
21.89M
7.94M
-29.83M
-27.67M
-27.67M
-27.67M
-27.67M
-0.34
-0.34
-0.34
-27.67M
-27.67M
82.81M
82.81M

Balance sheet

NGM quarterly balance sheet
61.27M
61.27M
88.37M
88.37M
58.00K
156.44M
7.03M
168.87M
20.08M
20.23M
-724.01M
18.00K
148.64M
148.64M
12.42M
149.00K
2.98M

Cash flow

NGM quarterly cash flow
1.06M
111.00K
4.34M
-188.00K
111.00K
27.19M
27.38M
-22.96M
6.30M
Advertisement